IDEXX Laboratories (IDXX) Tops Q1 EPS by 6c; Guides Higher for FY09
More News related to IDXX
- IDEXX Labs (IDXX) Reports Q3 EPS of $0.52, Beats by 7c; Guides FY09, FY10
- IDEXX Laboratories Announces Third Quarter Results
- Trading Radar for 10/23: Microsoft (MSFT), Honeywell (HON), Schlumberger (SLB), Whirlpool (WHR) Report
- Northcoast Research Initiates Coverage on IDEXX Laboratories (IDXX) with a Buy
- IDEXX Laboratories to Release 2009 Third Quarter Financial Results
More News related to Earnings
- Ericsson (ERIC) Selected as Exclusive Supplier to MTS Allstream for High Speed Network
- Peregrine Pharma (PPHMD) Says Study of Phosphatidylserine-Targeting Antibody Doubles Survival Times in Animals with Aggressive Brain Cancer
- Merit Medical Systems (MMSI) Receives U.S. FDA 510(K) Clearance for Merit Laureate Guide Wire
- Teva Pharma (TEVA) Announces Generic Version of Prevacid Does Not Infringe on Patents
- NTELOS Holdings (NTLS) Announces Workforce Reductions; Estimates $1.5M Cash Severance
IDEXX Laboratories, Inc. (Nasdaq: IDXX) reports Q1 EPS of $0.43, 6 cents better than estimates. Revenues were $236.5 million vs. $243.64 million consensus.
Sees FY revenues of approximately $1.0 billion vs. consensus of $1.03 billion.
FY09 diluted EPS are expected to be between $1.86 to $1.90 as compared to previous guidance of $1.84 to $1.90. (Consensus is $1.84)
[SM]
Related Categories
EarningsGuidance
Stocks Mentioned
+0.43Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
